新的在线教育,以支持药剂师的临床决策技能
Liane Holmes1,2, Vicky Park1, Rona Honnet1,3
1Pharmacy, NHS Education for Scotland (NES), Glasgow, UK.
概括
药剂师可以通过新的在线模拟模块来提高他们的临床决策技能和信心. 这种专注于心肌梗塞的互动工具显著提高了自我报告的能力和对一般医疗环境的信心.
科学领域:
- 药房 教育 教育 药房 教育
- 临床决策 - 临床决策
- 数字健康数字健康
背景情况:
- 在英国从事高级实践的药剂师需要提高决策能力和信心,以确保安全的患者护理.
- 交互式在线模拟为开发这些关键临床决策技能提供了一个有希望的方法.
研究的目的:
- 设计,实施和评估旨在提高药剂师临床决策能力的创新在线教育.
主要方法:
- 开发了一个定制的,分支的基于场景的电子学习模块",药房临床决策:心肌梗塞 (MI) ".
- 该模块通过NHS Education for Scotland的Turas Learn平台向苏格兰各地的药剂师部署.
- 通过使用利克特类型问题的评估前后调查,从2021年8月到2022年5月,评估了34名学习者的信心和能力.
主要成果:
- 所有评估的领域,包括整体护理,血液结果解释和剂量调整,都显示出自我报告的能力和信心的统计显著增加 (p < 0.01).
- 质量反表明,该模块得到了积极的接待.
- 学习者对扩展的临床主题和更复杂的场景表示了兴趣.
结论:
- 开发的在线模拟模块有效地提高了药剂师在临床决策中的自我报告的信心和能力.
- 电子学习方法是药房实践中专业发展的可行和受欢迎的方法.
- 未来的代应该考虑更广泛的临床应用和增加的场景复杂性.
相关概念视频
Nursing Clinical Information System
Nursing Clinical Information System (NCIS)
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
Drug Administration and Therapy Phases: Overview
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Nonlinear Pharmacokinetics: Overview
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Dosage Regimens: Designs and Approaches
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...


